Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended31st March, 2025.2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Resultsof the Company for the Quarter/Year ended 31st March, 2025.3. To consider and approve the Audited Financial Statements, including the Balance Sheet, as at31st March, 2025 and the Statement of Profits and Loss and Cash flow, statement of change inequity and notes thereon for the year ended 31st March, 2025.4. To Appoint Vishakha Agrawal & Associates, Practicing Company Secretaries, as the SecretarialAuditor of the Company for FY 2024-25.5. Any other business with permission of the Chairman.